Federal Reserve Chairman Jerome Powell speaks at his news conference following the two-day meeting of the Federal Open Market Committee (FOMC) meeting on interest rate policy in Washington, January 29, 2020. Yuri Gripas | Reuters The Federal Reserve is expected to again promise to do whatever it takes to fix the economy at the same
Stock Market
2020 has been a crazy year for car rental firm Hertz (HTZ). The year – so far – has included a bankruptcy, a probable NYSE delisting, and a stupefying post-bankruptcy share price run up of 1,200% that still can’t compensate for an overall 90% year-to-date decline. Add in an attempt to cash in on the
Check out the companies making headlines after the bell: Starbucks — Shares of the coffee giant jumped 5% in extended trading after the company posted its third-quarter financial results. The company reported a third-quarter loss of 46 cents per share excluding some items on revenues of $4.22 billion. Analysts surveyed by Refinitiv expected as a loss of
by Chris Vermeulen of The Technical Traders Our research team continues to attempt to navigate the difficult market dynamics ahead as traders’ concerns related to continued global economic functions persist. We believe the US stock market has rallied well beyond sustainable levels and the recent move in the US Dollar and Precious Metals has issued a clear warning
DraftKings (DKNG) announced on Tuesday that it is now the first official betting operator of the PGA Tour. Financial terms of the collaboration with the organizer of US golf tours weren’t disclosed. The partnership marks an expansion of a multi-year content and marketing relationship between the online betting giant and the PGA Tour. Back in
Traders wearing masks arrive before the opening bell at the New York Stock Exchange (NYSE) on May 26, 2020 at Wall Street in New York City. Johannes Eisele | AFP | Getty Images Check out the companies making headlines in midday trading. McDonald’s — Shares of the restaurant chain slipped more than 2% after the company
by Shaun Richards The U.S. Mint made an unusual request last week. In a press release dated July 23, the bureau literally begged Americans to start putting coins back into circulation by spending or depositing them. As you may have noticed, people just aren’t making transactions with coinage like they used to. That’s especially the case now
Emergent BioSolutions Inc. (EBS) has signed a $174 million deal to provide contract development and manufacturing for AstraZeneca’s (AZN) COVID-19 vaccine candidate, AZD1222. As part of the agreement, Emergent will start this year to produce drug substance at large scale for commercial supply. The contract valid until 2021, follows a $87 million contract in June, which Emergent
A multiple sclerosis drug is manufactured at the Biogen Idec plant in Cambridge, Mass. Essdras M Suarez | The Boston Globe | Getty Images Check out the companies making headlines midday Monday: Biogen — A Morgan Stanley analyst upgraded the biopharma company to overweight from underweight and predicted a 30% rally in the stock over
The Street will be tuning into Facebook’s (FB) earnings call, when the social media giant reports Q2 financial results on Wednesday. Investors and market watchers alike will be keen to find out how the first full quarter spent under the coronavirus cloud has impacted Facebook’s balance sheet. The differing results for Facebook’s social media rivals
GP: A logo of a Virgin Galactic is seen outside the building during the company’s first day of trading on the New York Stock Exchange (NYSE) on October 28, 2019 in New York City. JOHANNES EISELE | AFP | Getty Images Check out the companies making headlines after the bell: F5 Networks — Shares of the
by AUSinUSA Source of this image. When the Trump admin ordered the HHS to take over data handling from the CDC, mulitple groups stated concern that it may lead to data tampering, particularly when the hospital data was removed from public view (ultimately this position was reversed). Retrospectively, the stagnation in increased Covid-19 cases we’ve
No doubt, 2020 has been the year of COVID-19. However, in tandem, it has also been the year of the biotech, or more precisely, the coronavirus-related biotech. The frantic global search for COVID-19 solutions has shone the spotlight on previously under-the-radar companies making an effort to extinguish the viral outbreak. You can now add BrainStorm
The dollar has become the world’s punching bag and it’s likely to stay that way for awhile. The world’s reserve currency benefited in a big way from a flight-to-safety, which drove it to a three-and-a-half year high in March as the coronavirus pandemic spread to the U.S. Now, as the world’s focus has shifted back
by UPFINA We have been reporting on the weak jobless claims readings for 6 weeks now. This latest report ended the record long 15 week decline in seasonally adjusted initial claims. With the revision from 1.3 million to 1.307 million, last week’s seasonally adjusted decline was only 3,000. The streak ending isn’t a big deal.
Solid Biosciences (SLDB) has announced that it has been notified by the U.S. Food and Drug Administration (FDA) that the company’s IGNITE DMD Phase I/II clinical trial remains on clinical hold. In November 2019, the FDA placed IGNITE DMD on clinical hold as the result of a serious adverse event (SAE) that occurred in the
by Charles Hugh-Smith The laughably hopeless hope is that by propping up the corpses, the populace will discern some faint flicker of life in the decaying carcasses and return to their free-spending ways. Call it cultural synchronicity, but it increasingly feels like we’re living in the 1979 Talking Heads song Life During Wartime, which was anchored by
Moderna (MRNA) said on Sunday that it has been awarded up to $472 million by the U.S. Biomedical Advanced Research and Development Authority (BARDA) to support late stage clinical development of its mRNA vaccine candidate (mRNA-1273) against COVID-19. The U.S. grant will be used to fund the drugmaker’s expanded Phase 3 study of mRNA-1273, which includes 30,000 participants
COVID-19 wasn’t always the talk of the Street. The rapid pace of climate change has made finding renewable energy sources and limiting pollution more important than ever before, and as such, the spotlight has landed on electric car companies. Already making some serious headway, demand is expected to persist in the long-term as more and
by Arkadiusz Sieron of Sunshine Profits European leaders stroke a historic deal that could be a game-changer and provide a support for the euro and gold against the U.S. dollar. Historic deal. Pivotal moment for Europe. On Monday, the EU leaders agreed on a massive economic stimulus plan, after a long and crotchety summit. If passed through the
LabCorp (LH) said that the U.S. Food and Drug Administration (FDA) on Friday granted its diagnostic antibody test emergency use for anyone whether they have COVID-19 symptoms or not. In addition, the FDA allowed LabCorp’s COVID-19 RT-PCR test to be used for pooled sample screening. The company’s matrixed pooled strategy for COVID-19 allows for larger groups
Artificial intelligence (AI) is a buzzword in tech these days. The term, which encompasses a range of technologies including machine learning and data analysis. The goal is to create systems that can perceive, learn, and reason in ways that mimic human capabilities. At its best, AI will allow machines to understand the gestalt of a
When you’re looking for strong investments that will protect your resources and provide returns, even during these crazy coronavirus days, take a cue from Wall Street’s best analyst. Brent Bracelin, of the Piper Sandler research firm, rates 5 stars from TipRanks – but even better, he currently holds the #1 spot out of 6,815 analysts
Take a look at some of the biggest movers in the premarket: Biogen (BIIB) – The drugmaker reported quarterly earnings of $10.26 per share, compared to a consensus estimate of $8.03 a share. Revenue came in above estimates as well, helped by about $100 million in accelerated sales due to the Covid-19 pandemic. Biogen also slightly
Monday July 20 offered hope that the fight against the coronavirus might be progressing to the next stage. Interim data for AZD1222, a COVID-19 vaccine candidate AstraZeneca is developing with Oxford University, showed “strong” antibody and immune T-cell responses were generated in an ongoing Phase 1/2 trial. So, what does this mean for other biotechs
Take a look at some of the biggest movers in the premarket: Verizon (VZ) – Verizon reported quarterly profit of $1.18 per share, 3 cents a share above estimates. Revenue beat forecasts as well. Verizon said it experienced a negative impact from Covid-19, which hurt wireless service and ad spending revenue. American Express (AXP) –
by Przemyslaw Radomski via Sunshine Profits Everyone and their brother seem to think that gold mining stocks can only go up. In reality, the opposite is most likely for the next few days – weeks. This is probably the final warning that you read about the decline before it happens. The very bearish indications for the mining stocks
If one of your new year resolutions was to take out a position in vaccine specialist Novavax (NVAX), then congratulations. The risk tolerant investment in a penny stock going for $3.99 a piece at the turn of year has paid off and then some. You are now looking at a stock worth $140.69, having gained
From Birch Gold Group The Fed just announced a major shift in its approach to inflation, and the move is not getting nearly the attention that it deserves. That is, of course, unless you don’t mind inflation moving higher than any other time in recent memory. Writing for ThinkAdvisor, Tim Duy, senior director of the Oregon
In a summer of unending news, we may be heading into what could be the newsiest week of all. The Nasdaq’s sputtering rally could be put to its biggest test yet, as tech bellwether Apple and other stalwarts of the tech rally report earnings. Early in the week, Republicans will unveil their stimulus package proposal, which